DJIA 18,129.65 32.75 0.18%
NASDAQ 4,981.33 14.19 0.29%
S&P 500 2,100.85 2.32 0.11%
market minute promo

Express Scripts (NASDAQ: ESRX)

company name or ticker
Company Photos
(Click to zoom)

Rite Aid PBM Purchase Differentiates It From CVS and Walgreens

Achillion: Hep C Drug Discounting May Hurt Our Market Value, Stock Price

3 Blockbuster Drugs That May Be Obsolete in 5 Years

Motley Fool experts highlight three blockbuster-selling therapies that could fall by the wayside in the next five years.

5 Key Findings After 1 Full Year of Obamacare

Express Scripts offers five key takeaways on drug spending tied to Obamacare exchange plans.

Can Gilead Boost HCV Sales with Health Service Deals? - Analyst Blog

Gilead Sciences Offering Fresh Wave Of Competition To AbbVie's Viekira Pak

VUG, UPS, AGN, ESRX: Large Outflows Detected at ETF

Thornburg Value Fund Q4 2014 Commentary

AbbVie Inc. Earnings: After a Strong Year, Eyes Shift to 2015

AbbVie Inc's earnings report set the stage for 2015.

5 Things AbbVie Inc.'s Management Wants You to Know

How AbbVie is doing and what lies ahead -- straight from the company's executives.
See More Articles...